The effect of two new semi-synthetic glycosaminoglycans (G871, G872) on the zeta potential of calcium oxalate crystals and on growth and agglomeration.

[1]  F. Coe,et al.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. , 1989, The American journal of physiology.

[2]  E. Kaiser,et al.  Protein inhibitors of crystal growth. , 1989, The Journal of urology.

[3]  Michael J. Bernstein.  Prevention and treatment of kidney stones. , 1989, The Journal of urology.

[4]  D. Kok,et al.  Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. , 1988, Kidney international.

[5]  Y. Nakagawa,et al.  Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. , 1987, The Journal of clinical investigation.

[6]  W. Robertson,et al.  Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine. , 1986, The Journal of urology.

[7]  M. Peacock,et al.  Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers. , 1984, British journal of urology.

[8]  L. Smith,et al.  Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth. , 1984, The Journal of urology.

[9]  J. Schmidt,et al.  Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. , 1983, The Journal of urology.

[10]  M. R. Brown,et al.  The synthesis and characterization of N-sulfo-2-amino tricarballylate: an analog of phosphocitrate and inhibitor of calcification. , 1983, Analytical biochemistry.

[11]  G. H. Nancollas,et al.  Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation. , 1980, Investigative urology.

[12]  P. Curreri,et al.  An electrophoretic study of calcium oxalate monohydrate , 1979 .

[13]  B. Finlayson,et al.  Physicochemical aspects of urolithiasis. , 1978, Kidney international.

[14]  M. Peacock,et al.  Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. , 1972, Clinical science.

[15]  M. Peacock,et al.  Calcium crystalluria in recurrent renal-stone formers. , 1969, Lancet.

[16]  H. Fleisch,et al.  Isolation from urine of pyrophosphate, a calcification inhibitor. , 1962, The American journal of physiology.

[17]  L. Seager,et al.  Oral penicillin in the treatment of neisserian infections. , 1946, The Journal of urology.

[18]  B. Fellström,et al.  Glycosaminoglycans as Inhibitors of Renal Stone Formation , 1989 .

[19]  H. Wedrén.  Effects of sodium pentosanpolysulphate on symptoms related to chronic non-bacterial prostatitis. A double-blind randomized study. , 1987, Scandinavian journal of urology and nephrology.

[20]  G. A. Rose,et al.  Magnesium reduces calcium oxalate crystal formation in human whole urine. , 1982, Clinical science.

[21]  R. Ryall,et al.  Interpretation of particle growth and aggregation patterns obtained from the Coulter counter: a simple theoretical model. , 1981, Investigative urology.